marketcap
Facebook
Twitter
Telegram
Report an ErrorAnnual report 2021
added 12-23-2023
BioDelivery Sciences International Balance Sheet 2011-2024 | BDSI
Annual Balance Sheet BioDelivery Sciences International
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | -33.1 M | -5.32 M | 7.83 M | 26.5 M | -2.75 M | -54.7 M | -58.3 M | -4 M | -63.2 M | -10.8 M |
Long Term Debt |
- | 78.5 M | 58.6 M | 51.7 M | 47.7 M | 29.3 M | 22.2 M | 4.17 M | 11.8 M | - | - |
Long Term Debt Current |
- | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | 78.7 M | 59.1 M | 57.3 M | 53.1 M | 50.1 M | 43 M | 5.71 M | 13.8 M | 2.72 M | 1.65 M |
Total Current Liabilities |
82.4 M | 53 M | 54 M | 21.5 M | 26.1 M | 19.9 M | 28.1 M | 29.2 M | 25 M | 23.2 M | 17.9 M |
Total Liabilities |
137 M | 132 M | 113 M | 78.8 M | 79.2 M | 70 M | 71.1 M | 34.9 M | 38.8 M | 26 M | 19.5 M |
Deferred Revenue |
- | - | - | - | - | 1.72 M | 1.88 M | 6.77 M | 2.93 M | 7.99 M | 12.5 M |
Retained Earnings |
-256 M | -341 M | -367 M | -351 M | -305 M | -310 M | -243 M | -206 M | -151 M | -93.9 M | -95.6 M |
Total Assets |
325 M | 240 M | 183 M | 109 M | 88.1 M | 52.3 M | 103 M | 89.3 M | 38 M | 75.7 M | 23.6 M |
Cash and Cash Equivalents |
- | 112 M | 63.9 M | 43.8 M | 21.2 M | 32 M | 83.6 M | 70.5 M | 23.2 M | 63.2 M | 10.8 M |
Book Value |
188 M | 108 M | 69.8 M | 29.7 M | 8.88 M | -17.7 M | 31.7 M | 54.4 M | -812 K | 49.8 M | 4.12 M |
Total Shareholders Equity |
188 M | 108 M | 69.8 M | 29.7 M | 8.88 M | -17.7 M | 31.7 M | 54.4 M | -812 K | 49.8 M | 4.12 M |
All numbers in USD currency
Quarterly Balance Sheet BioDelivery Sciences International
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | - | 219 K | - | - | - | 213 K | - | - | - | 540 K | 615 K | 687 K | 755 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | - | - | - | 137 M | 133 M | 136 M | 133 M | 132 M | 132 M | 135 M | 120 M | 113 M | 113 M | 113 M | 113 M | 78.8 M | 78.8 M | 78.8 M | 78.8 M | 79.2 M | 79.2 M | 79.2 M | 79.2 M | 69.4 M | 70 M | 70 M | 70 M | 71.1 M | 71.1 M | 71.1 M | 71.1 M | 34.4 M | 34.9 M | 34.9 M | 34.9 M | 38.8 M | 38.8 M | 38.8 M | 38.8 M | 26 M | 26 M | 26 M | 26 M | 19.5 M | 19.5 M | 19.5 M | 19.5 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.72 M | 1.72 M | 1.72 M | 1.72 M | 1.88 M | 1.88 M | 1.88 M | 1.88 M | 6.77 M | 6.77 M | 6.77 M | 6.77 M | 2.93 M | 2.93 M | 2.93 M | 2.93 M | 7.99 M | 7.99 M | 7.99 M | 7.99 M | 12.5 M | 12.5 M | 12.5 M | 12.5 M |
Retained Earnings |
- | - | - | - | -256 M | -320 M | -327 M | -336 M | -341 M | -351 M | -360 M | -362 M | -367 M | -367 M | -367 M | -367 M | -351 M | -351 M | -351 M | -351 M | -305 M | -305 M | -305 M | -305 M | -310 M | -310 M | -310 M | -310 M | -243 M | -243 M | -243 M | -243 M | -206 M | -206 M | -206 M | -206 M | -151 M | -151 M | -151 M | -151 M | -93.9 M | -93.9 M | -93.9 M | -93.9 M | -95.6 M | -95.6 M | -95.6 M | -95.6 M |
Total Assets |
- | - | - | - | 325 M | 256 M | 250 M | 242 M | 240 M | 228 M | 220 M | 197 M | 183 M | 183 M | 183 M | 183 M | 109 M | 109 M | 109 M | 109 M | 88.1 M | 88.1 M | 88.1 M | 88.1 M | 51.7 M | 52.3 M | 52.3 M | 52.3 M | 103 M | 103 M | 103 M | 103 M | 88.8 M | 89.3 M | 89.3 M | 89.3 M | 38 M | 38 M | 38 M | 38 M | 75.7 M | 75.7 M | 75.7 M | 75.7 M | 23.6 M | 23.6 M | 23.6 M | 23.6 M |
Cash and Cash Equivalents |
- | - | - | - | 114 M | 101 M | 120 M | 116 M | 112 M | 112 M | 112 M | 112 M | 63.9 M | 63.9 M | 63.9 M | 63.9 M | 43.8 M | 43.8 M | 43.8 M | 43.8 M | 21.2 M | 21.2 M | 21.2 M | 21.2 M | 32 M | 32 M | 32 M | 32 M | 83.6 M | 83.6 M | 83.6 M | 83.6 M | 70.5 M | 70.5 M | 70.5 M | 70.5 M | 23.2 M | 23.2 M | 23.2 M | 23.2 M | 63.2 M | 63.2 M | 63.2 M | 63.2 M | 10.8 M | 10.8 M | 10.8 M | 10.8 M |
Book Value |
- | - | - | - | 188 M | 123 M | 114 M | 109 M | 108 M | 95.9 M | 84.8 M | 76.6 M | 69.8 M | 69.8 M | 69.8 M | 69.8 M | 29.7 M | 29.7 M | 29.7 M | 29.7 M | 8.88 M | 8.88 M | 8.88 M | 8.88 M | -17.7 M | -17.7 M | -17.7 M | -17.7 M | 31.7 M | 31.7 M | 31.7 M | 31.7 M | 54.4 M | 54.4 M | 54.4 M | 54.4 M | -812 K | -812 K | -812 K | -812 K | 49.8 M | 49.8 M | 49.8 M | 49.8 M | 4.12 M | 4.12 M | 4.12 M | 4.12 M |
Total Shareholders Equity |
- | - | - | - | 188 M | 123 M | 114 M | 109 M | 108 M | 95.9 M | 84.8 M | 76.6 M | 69.8 M | 67.9 M | 66.2 M | 69.8 M | 29.7 M | 29.7 M | 29.7 M | 29.7 M | 8.88 M | 8.88 M | 8.88 M | 8.88 M | -17.7 M | -17.7 M | -17.7 M | -17.7 M | 31.7 M | 31.7 M | 31.7 M | 31.7 M | 54.4 M | 54.4 M | 54.4 M | 54.4 M | -812 K | -812 K | -812 K | -812 K | 49.8 M | 49.8 M | 49.8 M | 49.8 M | 4.12 M | 4.12 M | 4.12 M | 4.12 M |
All numbers in USD currency